KLHL5 knockdown increases cellular sensitivity to anticancer drugs
Open Access
- 21 December 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (100) , 37429-37438
Abstract
KLHL5 knockdown increases cellular sensitivity to anticancer drugs KLHL5 knockdown increases cellular sensitivity to anticancer drugsKeywords
This publication has 24 references indexed in Scilit:
- KLHL21, a novel gene that contributes to the progression of hepatocellular carcinomaBMC Cancer, 2016
- Cortical dynamics during cell motility are regulated by CRL3KLHL21 E3 ubiquitin ligaseNature Communications, 2016
- Kelch-like Protein 21 (KLHL21) Targets IκB Kinase-β to Regulate Nuclear Factor κ-Light Chain Enhancer of Activated B Cells (NF-κB) Signaling NegativelyJournal of Biological Chemistry, 2016
- CUL3 and protein kinases: Insights from PLK1/KLHL22 interactionCell Cycle, 2013
- Update on the Kelch-like (KLHL) gene familyHuman Genomics, 2013
- The Cul3–KLHL21 E3 ubiquitin ligase targets Aurora B to midzone microtubules in anaphase and is required for cytokinesisJournal of Cell Biology, 2009
- Born to bind: the BTB protein–protein interaction domainBioEssays, 2006
- The BACK domain in BTB-kelch proteinsTrends in Biochemical Sciences, 2004
- The kelch repeat superfamily of proteins: propellers of cell functionTrends in Cell Biology, 2000
- Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domainGenes & Development, 1999